Leidos shares dropped 9.3% post-earnings on concerns about a cautious outlook and potential near-term margin pressures despite reported revenue growth and revenue guidance raise.

• Q1 revenue increased 4% year-on-year to $4.4 billion, with adjusted EBITDA margin at 14%.
• Company raised 2026 revenue guidance by $500 million, EPS by $0.05, and operating cash flow by $50 million, citing strong core performance and accretive acquisition benefits.
• Major contract milestones include serial production start on $2.2 billion ALPS passive sensing system and over $9 billion in Defense Tech awards in the past 15 months.
• Growth pillars emphasized: Defense Tech, managed health, digital infrastructure and cyber, energy resilience, and mission software.
• Despite positive business developments, the sizable share price decline suggests investor skepticism around sustainable growth, margin stability, or possibly cautious language in outlook not fully offset by reported metrics.